rs587777893
Variant summary
Our verdict is Pathogenic. Variant got 17 ACMG points: 17P and 0B. PM1PM2PM5PP2PP3_ModeratePP5_Very_Strong
The NM_004958.4(MTOR):c.5930C>T(p.Thr1977Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T1977K) has been classified as Pathogenic.
Frequency
Consequence
NM_004958.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 17 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MTOR | NM_004958.4 | c.5930C>T | p.Thr1977Ile | missense_variant | 43/58 | ENST00000361445.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MTOR | ENST00000361445.9 | c.5930C>T | p.Thr1977Ile | missense_variant | 43/58 | 1 | NM_004958.4 | P1 |
Frequencies
GnomAD3 genomes ? Cov.: 33
GnomAD4 exome Cov.: 33
GnomAD4 genome ? Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Apr 22, 2023 | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects MTOR function (PMID: 27159400). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MTOR protein function. ClinVar contains an entry for this variant (Variation ID: 584432). This missense change has been observed in individuals with clinical features of MTOR-related conditions (PMID: 27159400, 30569621, 33833411). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 1977 of the MTOR protein (p.Thr1977Ile). - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 05, 2022 | Published functional studies demonstrate constitutive activation of mTOR complex 1 and enlarged neuronal size (Mirzaa et al., 2016); Not observed in large population cohorts (gnomAD); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 27159400, 30569621) - |
MTOR-related megalencephaly and pigmentary mosaicism in skin Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Undiagnosed Diseases Network, NIH | May 11, 2018 | A mosaic c.5930C>T (p.T1977I) pathogenic variant in the MTOR gene was detected in this individual (level of mosaicism 32%, 55 mutant and 117 reference reads). This variant has been previously reported as mosaic in 3 unrelated children with diffuse megalencephaly and pigmentary mosaicism in skin [PMID 27159400]. This variant has also been seen as mosaic in one internal patient with macrocephaly, overgrowth, and other similar symptoms. This individual has been reported in PMID: 30569621. - |
Isolated focal cortical dysplasia type II Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Undiagnosed Diseases Network, NIH | Aug 23, 2019 | - - |
CEBALID syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Equipe Genetique des Anomalies du Developpement, Université de Bourgogne | Sep 01, 2020 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at